Solventum Corporation (SOLV)
NYSE
Closed
Aug 24, 2026
Day's Range
89.5052 wk Range
62.38Overview - SOLV - Solventum Corporation
Key Statistics
Valuation
Enterprise Value
20.13B
P/E (Trailing)
‪10.94‬
P/E (Forward)
‪12.39‬
PEG Ratio
‪5.69‬
Price / Sales (TTM)
‪1.83‬
Price / Book
‪3.12‬
EV / EBITDA
‪17.68‬
Profitability
Gross Margin
‪58.21%‬
Profit Margin
‪17.25%‬
Operating Margin
‪9.77%‬
Return on Assets
‪2.69%‬
Return on Equity
‪33.96%‬
Ownership
Shares Outstanding
170.11M
Float
144.13M
Short % of Shares Outstanding
‪2.43%‬
Held by Insiders
‪15.31%‬
Held by Institutions
‪76.01%‬
Price stats
Beta
‪0.67‬
50-Day Avg
‪80.98‬
200-Day Avg
‪76.42‬
Dividends
Payout Ratio
‪0.00%‬
Analyst Consensus
15 analysts
Average price target
‪$ 93.92‬Shariah Compliance
Report Date: Feb 17, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - SOLV - Solventum Corporation
Peers - SOLV - Solventum Corporation
Peer Comparison
Compared with companies in Medical Instruments & Supplies listed on NYSE.
Profile Summary - SOLV - Solventum Corporation
About
Solventum Corporation is a healthcare company that develops, manufactures, and commercializes solutions leveraging material science, data science, and digital capabilities to address customer and patient needs. It operates through three primary segments: MedSurg, which provides wound therapy, I.V. site management,…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
